RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX) Is Adding More Indications For RGN-259
RegeneRxBiopharmaceuticals Inc (OTCMKTS:RGRX) is down 10%. The company had previously closed at $0.20 but is now at $0.18. This could be a good time for investors to buy stock as they would get it at a lower price. Trading Data On Wednesday, RGRX stock slid 10% to $0.18 with more than 24K shares, compared to its average volume of 38K shares. The stock moved within a range of $0.1750 –…